Elevance Health (ELV) Change in Account Payables (2010 - 2026)

Elevance Health (ELV) has reported Change in Account Payables for 17 consecutive years, with -$374.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Account Payables fell 75.59% year-over-year to -$374.0 million; the TTM figure through Jun 2026 stood at $1.1 billion (up 1314.94% YoY), while the FY2025 annual figure was $228.0 million, up 112.39% from the prior year.
• Change in Account Payables fell to -$374.0 million in Q2 2026 per ELV's latest filing, from $1.6 billion in the prior quarter.
• Across five years, Change in Account Payables topped out at $1.6 billion in Q1 2026 and bottomed at -$1.4 billion in Q2 2024.
• Historically, Change in Account Payables has averaged $120.1 million across 5 years, with a median of $35.5 million in 2022.
• Annual changes were most pronounced in 2023 — Change in Account Payables slumped 725.0% — and 2025, when it jumped 4032.14%.
• Elevance Health's Change in Account Payables stood at $823.0 million in 2022, then plunged by 122.6% to -$186.0 million in 2023, then surged by 84.95% to -$28.0 million in 2024, then surged by 4032.14% to $1.1 billion in 2025, then plunged by 133.97% to -$374.0 million in 2026.
• Business Quant data shows ELV's Change in Account Payables at -$374.0 million in Q2 2026, $1.6 billion in Q1 2026, and $1.1 billion in Q4 2025.